H R Adams
Overview
Explore the profile of H R Adams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams H, Augustine E, Bonifacio K, Collins A, Danielson M, Mink J, et al.
Evid Based Pract Child Adolesc Ment Health
. 2024 Jun;
9(2):216-230.
PMID: 38883231
Tics and tic disorders can significantly impact children, but limited screening tools and diagnostic challenges may delay access to care. The current study attempted to address these gaps by evaluating...
2.
Eisengart J, Daniel M, Adams H, Williams P, Kuca B, Shapiro E
Mol Genet Metab
. 2022 Sep;
137(1-2):201-209.
PMID: 36115283
Due to the surge in new brain-directed treatments, metrics to detect the alteration in developmental trajectories in cognition and adaptive behavior have become increasingly important. We propose Growth Scale Values...
3.
Augustine E, Adams H, Bitsko R, Van Wijngaarden E, Claussen A, Thatcher A, et al.
Pediatr Neurol
. 2017 Mar;
68:49-58.e3.
PMID: 28254245
Background: Tic disorders, including Tourette syndrome, are complex, multisymptom diseases, yet the impact of these disorders on affected children, families, and communities is not well understood. Methods: To improve the...
4.
Plumb J, Smyth L, Adams H, Vestbo J, Bentley A, Singh S
Eur Respir J
. 2009 Feb;
34(1):89-94.
PMID: 19196820
Lymphoid follicles in the lung parenchyma are a characteristic feature of chronic obstructive pulmonary disease (COPD). There are reports of altered CD4 T-regulatory cell numbers in COPD lungs, but the...
5.
Jones J, Sturek M, Adams H, Parker J
Shock
. 2001 May;
15(5):386-91.
PMID: 11336199
Impairment in endothelial cell intracellular free calcium (Ca(i)) mobilization mechanisms may contribute to decreased nitric oxide (NO) biosynthesis and impaired vasorelaxation responses of endotoxemic guinea pigs to endothelium-dependent vasodilators. We...
6.
Carson R, Lang L, Watabe H, Der M, Adams H, Jagoda E, et al.
Nucl Med Biol
. 2000 Aug;
27(5):493-7.
PMID: 10962257
We synthesized [(18)F]FCWAY, an analog of [carbonyl-(11)C]WAY-100635 ¿[(11)C]N-(2-(1-(4-(2-methoxyphenyl)-piperazinyl)ethyl))-N-(2-(pyridi nyl))cyclohexanecarboxamide¿, by replacing the cyclohexanecarbonyl group acid with a trans-4-fluorocyclohexanecarbonyl group (FC). Control and preblocking studies were performed in anesthetized monkeys. Plasma...
7.
Watabe H, Channing M, Der M, Adams H, Jagoda E, Herscovitch P, et al.
J Cereb Blood Flow Metab
. 2000 Jul;
20(6):899-909.
PMID: 10894173
The goal of this study was to develop a suitable kinetic analysis method for quantification of 5-HT2A receptor parameters with [11C]MDL 100,907. Twelve control studies and four preblocking studies (400...
8.
9.
Myers T, Myers P, Adams H, Parker J
Shock
. 1999 Aug;
11(6):436-42.
PMID: 10454834
Endotoxemia secondary to gram-negative sepsis has been shown to inhibit endothelium-dependent vasomotion in numerous vascular beds, including guinea pig aortae and coronary arteries. We tested the hypothesis that in vivo...
10.
Lang L, Jagoda E, Schmall B, Vuong B, Adams H, Nelson D, et al.
J Med Chem
. 1999 May;
42(9):1576-86.
PMID: 10229627
We have synthesized five fluorinated derivatives of WAY 100635, N-{2-[4-(2-methoxyphenyl)piperazino]ethyl}-N-(2-pyridyl)cyclohe xaneca rboxamide (4a), using various acids in place of the cyclohexanecarboxylic acid (CHCA, 2a) in the reaction scheme. The five...